
CME's 11% YTD Gain: Is the Stock Overvalued at 23.82X P/E?
CME Group, a leading derivatives marketplace, has gained 11% YTD, with a PE of 23.82x. The company's strong performance is driven by increased trading volumes and market share gains. With its solid fundamentals and attractive valuation, now may be a good time to buy the stock.